$48.12
-0.58-1.19%
最終更新: Nov 12, 9:03 AM
Benzinga
Benzinga
Benzinga
木曜日, 11 12
Benzinga
© 2026 Benzinga | All Rights Reserved
Omega Healthcare Investors rose 10.2% from $43.67 to $48.12, behind the S&P 500's +11.2%. Its worst day was Mar 20 (−4.3%), and its low came Feb 3 at $42.93.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.80 beat the $0.60 estimate on $319.2M revenue (est. $288.4M); FY EPS guidance of $3.15–$3.25 against the $2.46 consensus.
+6.1%, the year's best day · S&P 500 −1.2%
Story events cover the past 12 months · Times ET
Omega Healthcare Investors shares fell 4.3%, while the S&P 500 fell 1.4%.
−4.3%, the year's worst day · S&P 500 −1.4%
EPS of $0.82 beat the $0.77 estimate on $323.0M revenue (est. $276.6M); FY EPS guidance of $3.19–$3.25 against the $3.07 consensus.
−1.5% · S&P 500 0.0%
Omega Healthcare Investors shares rose 4.3%, while the S&P 500 fell 0.3%.
+4.3% · S&P 500 −0.3%
Omega Healthcare Investors shares rose 4.0%, while the S&P 500 fell 0.5%.
+4.0% · S&P 500 −0.5%
EPS of $0.83 beat the $0.77 estimate on $328.2M revenue (est. $283.1M); FY EPS guidance of $3.22–$3.26 against the $3.10 consensus.
−1.9% · S&P 500 +1.7%
Omega Healthcare Investors shares fell 3.8%, while the S&P 500 fell 0.3%.
−3.8% · S&P 500 −0.3%
Omega Healthcare Investors shares rose 4.2%, while the S&P 500 fell 1.2%.
+4.2% · S&P 500 −1.2%
EPS of $0.82 beat the $0.78 estimate on $340.6M revenue (est. $283.0M); FY EPS guidance of $3.28–$3.30 against the $3.12 consensus.
+2.0% · S&P 500 +1.7%
Where it ended: a close of $48.12 on Nov 11, 2026. Up next: Q4 2026 earnings on Feb 3, 2027 (EPS est. $0.79, revenue est. $332.3M).
As of the Nov 11, 2026 close
Replay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for OHI and SPY from Benzinga historical bars. Not investment advice.